Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.
Anaplastic Astrocytoma - Pipeline Review, H2 2019
By Global Markets Direct | Pharmaceuticals and Healthcare | Dec 2019 | Page 238
Anaplastic Astrocytoma - Pipeline Review, H2 2019 latest Pharmaceutical and Healthcare disease pipeline guide Anaplastic Astrocytoma - Pipeline Review, H2 2019, provides an overview of the Anaplastic Astrocytoma (Oncology) pipeline landscape. Anaplastic....
Medulloblastoma - Pipeline Review, H2 2019
By Global Markets Direct | Pharmaceuticals and Healthcare | Dec 2019 | Page 346
Medulloblastoma - Pipeline Review, H2 2019 latest Pharmaceutical and Healthcare disease pipeline guide Medulloblastoma - Pipeline Review, H2 2019, provides an overview of the Medulloblastoma (Oncology) pipeline landscape. Medulloblastoma is the most....
Chondrosarcoma - Pipeline Review, H2 2019
By Global Markets Direct | Pharmaceuticals and Healthcare | Dec 2019 | Page 418
Chondrosarcoma - Pipeline Review, H2 2019 latest Pharmaceutical and Healthcare disease pipeline guide Chondrosarcoma - Pipeline Review, H2 2019, provides an overview of the Chondrosarcoma (Oncology) pipeline landscape. Chondrosarcoma is a malignant....
Bone Metastasis - Pipeline Review, H2 2019
By Global Markets Direct | Pharmaceuticals and Healthcare | Dec 2019 | Page 133
Bone Metastasis - Pipeline Review, H2 2019 latest Pharmaceutical and Healthcare disease pipeline guide Bone Metastasis - Pipeline Review, H2 2019, provides an overview of the Bone Metastasis (Oncology) pipeline landscape. Bone....
Essential Thrombocythemia - Pipeline Review, H2 2019
By Global Markets Direct | Pharmaceuticals and Healthcare | Dec 2019 | Page 111
Essential Thrombocythemia - Pipeline Review, H2 2019 latest Pharmaceutical and Healthcare disease pipeline guide Essential Thrombocythemia - Pipeline Review, H2 2019, provides an overview of the Essential Thrombocythemia (Oncology) pipeline landscape. Essential....